Literature DB >> 5276692

A surgical approach to plerocephalic disc oedema.

S I Davidson.   

Abstract

Entities:  

Mesh:

Year:  1970        PMID: 5276692

Source DB:  PubMed          Journal:  Trans Ophthalmol Soc U K        ISSN: 0078-5334


× No keyword cloud information.
  9 in total

Review 1.  Optic nerve sheath decompression: neuropathologic, clinical, and hemodynamic results and rationale.

Authors:  R C Sergott
Journal:  Trans Am Ophthalmol Soc       Date:  1991

2.  Surgical treatment of chronic papilloedema in children.

Authors:  F A Billson; R L Hudson
Journal:  Br J Ophthalmol       Date:  1975-02       Impact factor: 4.638

3.  Treatment of benign intracranial hypertension by dehydrating agents with particular reference to the measurement of the blind spot area as a means of recording improvement.

Authors:  A Jefferson; J Clark
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-07       Impact factor: 10.154

4.  Benign intracranial hypertension treated by optic nerve sheath decompression.

Authors:  C M Tomkins; D J Spalton
Journal:  J R Soc Med       Date:  1984-02       Impact factor: 5.344

5.  Optic nerve sheath fenestration: a revised lateral approach for nerve access.

Authors:  Nathan W Blessing; David T Tse
Journal:  Orbit       Date:  2018-03-22

6.  Histopathological and ultrastructural examination of optic nerve sheath decompression.

Authors:  J C Tsai; M S Petrovich; A A Sadun
Journal:  Br J Ophthalmol       Date:  1995-02       Impact factor: 4.638

7.  Macular changes resulting from papilloedema.

Authors:  A T Morris; M D Sanders
Journal:  Br J Ophthalmol       Date:  1980-03       Impact factor: 4.638

8.  Benign intracranial hypertension: visual loss and optic nerve sheath fenestration.

Authors:  R S Knight; A R Fielder; J L Firth
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-03       Impact factor: 10.154

9.  Optic nerve sheath decompression for visual loss in intracranial hypertension: report from a tertiary care center in South India.

Authors:  Suneetha Nithyanandam; George J Manayath; Ravindra R Battu
Journal:  Indian J Ophthalmol       Date:  2008 Mar-Apr       Impact factor: 1.848

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.